Literature DB >> 30308331

Cancer associated fibroblasts: is the force the path to the dark side?

Jorge Barbazán1, Danijela Matic Vignjevic2.   

Abstract

The most abundant cell type in the tumor microenvironment are cancer-associated fibroblasts (CAFs). CAFs play an important role in tumor growth and progression. Besides direct communication with cancer cells via secreted molecules or cell-cell adhesions, CAFs also indirectly affect cancer cell behavior by remodeling the extracellular matrix (ECM). Here, we summarize recent findings on the distinct mechanisms that CAFs use to modify ECM, specifically, their proteolytic versus force-dependent activity. We then review the consequences of CAF force transmission on the physico-chemical properties of the matrix, focusing on the deposition of new matrix components, and the alteration of the organization and stiffness of the ECM. CAFs promote tumor invasion by creating the roads cancer cells use to escape the tumor mass. However, there is also evidence that CAFs can prevent invasion, possibly by forming a physical barrier around the tumor edge. We discuss the controversial role of CAFs in tumor progression.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30308331     DOI: 10.1016/j.ceb.2018.09.002

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  35 in total

Review 1.  Cancer-associated fibroblasts: how do they contribute to metastasis?

Authors:  Mei Qi Kwa; Kate M Herum; Cord Brakebusch
Journal:  Clin Exp Metastasis       Date:  2019-03-07       Impact factor: 5.150

Review 2.  The Tumor Microenvironment: An Introduction to the Development of Microfluidic Devices.

Authors:  B Kundu; D Caballero; C M Abreu; R L Reis; S C Kundu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts.

Authors:  Sonakshi Bhattacharjee; Florian Hamberger; Aashreya Ravichandra; Maximilian Miller; Ajay Nair; Silvia Affo; Aveline Filliol; LiKang Chin; Thomas M Savage; Deqi Yin; Naita Maren Wirsik; Adam Mehal; Nicholas Arpaia; Ekihiro Seki; Matthias Mack; Di Zhu; Peter A Sims; Raghu Kalluri; Ben Z Stanger; Kenneth P Olive; Thomas Schmidt; Rebecca G Wells; Ingmar Mederacke; Robert F Schwabe
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 14.808

4.  Activated fibroblasts enhance cancer cell migration by microvesicles-mediated transfer of Galectin-1.

Authors:  Alessandra Toti; Alice Santi; Elisa Pardella; Ilaria Nesi; Richard Tomasini; Tommaso Mello; Paolo Paoli; Anna Caselli; Paolo Cirri
Journal:  J Cell Commun Signal       Date:  2021-05-22       Impact factor: 5.782

5.  Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.

Authors:  Silvia Affo; Ajay Nair; Francesco Brundu; Aashreya Ravichandra; Sonakshi Bhattacharjee; Michitaka Matsuda; LiKang Chin; Aveline Filliol; Wen Wen; Xinhua Song; Aubrianna Decker; Jeremy Worley; Jorge Matias Caviglia; Lexing Yu; Deqi Yin; Yoshinobu Saito; Thomas Savage; Rebecca G Wells; Matthias Mack; Lars Zender; Nicholas Arpaia; Helen E Remotti; Raul Rabadan; Peter Sims; Anne-Laure Leblond; Achim Weber; Marc-Oliver Riener; Brent R Stockwell; Jellert Gaublomme; Josep M Llovet; Raghu Kalluri; George K Michalopoulos; Ekihiro Seki; Daniela Sia; Xin Chen; Andrea Califano; Robert F Schwabe
Journal:  Cancer Cell       Date:  2021-04-29       Impact factor: 38.585

Review 6.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04

7.  LncRNA H19 promotes keloid formation through targeting the miR-769-5p/EIF3A pathway.

Authors:  Lingang Xu; Nan Sun; Guangshuai Li; Linbo Liu
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 8.  Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment.

Authors:  María Belén Giorello; Francisco Raúl Borzone; Vivian Labovsky; Flavia Valeria Piccioni; Norma Alejandra Chasseing
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-04       Impact factor: 2.673

Review 9.  Interfering with Tumor Hypoxia for Radiotherapy Optimization.

Authors:  Irma Telarovic; Roland H Wenger; Martin Pruschy
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21

10.  Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents.

Authors:  Jyoti Roy; Suraj U Hettiarachchi; Miranda Kaake; Ramesh Mukkamala; Philip S Low
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.